Keywords: astrazeneca, symbicort, 100/6, turbohaler, granted, uk, license

AstraZeneca's Symbicort 100/6 Turbohaler granted UK license for use in children

Article | 12 August 2002

Print This

AstraZeneca's Symbicort 100/6 Turbohaler (budesonide/ eformoterol)has been granted a license in the UK for use in children aged six to 11 ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in